Drug of Abuse Testing Services Market Size, Share, and Growth Forecast for 2025 - 2032

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Investment Feasibility Matrix

    3.6. PESTLE and Porter’s Analysis

    3.7. Regulatory Landscape

        3.7.1. By Key Regions

        3.7.2. By Key Countries

    3.8. Regional Parent Market Outlook

4. Global Drug of Abuse Testing Services Market Analysis, 2019 - 2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Drug of Abuse Testing Services Market Analysis, 2019 - 2032, By Drug Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Drug Type, 2019-2023

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Drug Type, 2024-2032

        5.3.1. Alcohol

        5.3.2. Cannabis/Marijuana

        5.3.3. Cocaine

        5.3.4. Opioids

        5.3.5. Amphetamine & Methamphetamine

        5.3.6. LSD

        5.3.7. Other Drug Types

    5.4. Y-o-Y Growth Trend Analysis By Drug Type, 2019-2023

    5.5. Absolute $ Opportunity Analysis By Drug Type, 2024-2032

6. Global Drug of Abuse Testing Services Market Analysis, 2019 - 2032, By Region

    6.1. Introduction

    6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023

    6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032

        6.3.1. North America

        6.3.2. Latin America

        6.3.3. Europe

        6.3.4. Asia Pacific

        6.3.5. Middle East and Africa

    6.4. Market Attractiveness Analysis By Region

7. North America Drug of Abuse Testing Services Market Analysis, 2019 - 2032, By Country

    7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023

    7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032

        7.2.1. By Country

            7.2.1.1. U.S.

            7.2.1.2. Canada

        7.2.2. By Drug Type

    7.3. Market Attractiveness Analysis

        7.3.1. By Country

        7.3.2. By Drug Type

    7.4. Key Takeaways

8. Latin America Drug of Abuse Testing Services Market Analysis, 2019 - 2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032

        8.2.1. By Country

            8.2.1.1. Brazil

            8.2.1.2. Mexico

            8.2.1.3. Rest of Latin America

        8.2.2. By Drug Type

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Drug Type

    8.4. Key Takeaways

9. Europe Drug of Abuse Testing Services Market Analysis, 2019 - 2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032

        9.2.1. By Country

            9.2.1.1. Germany

            9.2.1.2. U.K.

            9.2.1.3. France

            9.2.1.4. Spain

            9.2.1.5. Italy

            9.2.1.6. Russia

            9.2.1.7. Rest of Europe

        9.2.2. By Drug Type

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Drug Type

    9.4. Key Takeaways

10. Asia Pacific Drug of Abuse Testing Services Market Analysis, 2019 - 2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032

        10.2.1. By Country

            10.2.1.1. China

            10.2.1.2. Japan

            10.2.1.3. India

            10.2.1.4. South Korea

            10.2.1.5. Australia

            10.2.1.6. Rest of APAC

        10.2.2. By Drug Type

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Drug Type

    10.4. Key Takeaways

11. Middle East and Africa Drug of Abuse Testing Services Market Analysis, 2019 - 2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032

        11.2.1. By Country

            11.2.1.1. South Africa

            11.2.1.2. Saudi Arabia

            11.2.1.3. UAE

            11.2.1.4. Israel

            11.2.1.5. Rest of MEA

        11.2.2. By Drug Type

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Drug Type

    11.4. Key Takeaways

12. Key Countries Drug of Abuse Testing Services Market Analysis

    12.1. U.S.

        12.1.1. Pricing Analysis

        12.1.2. Market Share Analysis, 2023

            12.1.2.1. By Drug Type

    12.2. Canada

        12.2.1. Pricing Analysis

        12.2.2. Market Share Analysis, 2023

            12.2.2.1. By Drug Type

    12.3. Brazil

        12.3.1. Pricing Analysis

        12.3.2. Market Share Analysis, 2023

            12.3.2.1. By Drug Type

    12.4. Mexico

        12.4.1. Pricing Analysis

        12.4.2. Market Share Analysis, 2023

            12.4.2.1. By Drug Type

    12.5. Germany

        12.5.1. Pricing Analysis

        12.5.2. Market Share Analysis, 2023

            12.5.2.1. By Drug Type

    12.6. U.K.

        12.6.1. Pricing Analysis

        12.6.2. Market Share Analysis, 2023

            12.6.2.1. By Drug Type

    12.7. France

        12.7.1. Pricing Analysis

        12.7.2. Market Share Analysis, 2023

            12.7.2.1. By Drug Type

    12.8. Spain

        12.8.1. Pricing Analysis

        12.8.2. Market Share Analysis, 2023

            12.8.2.1. By Drug Type

    12.9. Italy

        12.9.1. Pricing Analysis

        12.9.2. Market Share Analysis, 2023

            12.9.2.1. By Drug Type

    12.10. Russia

        12.10.1. Pricing Analysis

        12.10.2. Market Share Analysis, 2023

            12.10.2.1. By Drug Type

    12.11. China

        12.11.1. Pricing Analysis

        12.11.2. Market Share Analysis, 2023

            12.11.2.1. By Drug Type

    12.12. Japan

        12.12.1. Pricing Analysis

        12.12.2. Market Share Analysis, 2023

            12.12.2.1. By Drug Type

    12.13. India

        12.13.1. Pricing Analysis

        12.13.2. Market Share Analysis, 2023

            12.13.2.1. By Drug Type

    12.14. South Korea

        12.14.1. Pricing Analysis

        12.14.2. Market Share Analysis, 2023

            12.14.2.1. By Drug Type

    12.15. Australia

        12.15.1. Pricing Analysis

        12.15.2. Market Share Analysis, 2023

            12.15.2.1. By Drug Type

    12.16. South Africa

        12.16.1. Pricing Analysis

        12.16.2. Market Share Analysis, 2023

            12.16.2.1. By Drug Type

    12.17. Saudi Arabia

        12.17.1. Pricing Analysis

        12.17.2. Market Share Analysis, 2023

            12.17.2.1. By Drug Type

    12.18. UAE

        12.18.1. Pricing Analysis

        12.18.2. Market Share Analysis, 2023

            12.18.2.1. By Drug Type

    12.19. Israel

        12.19.1. Pricing Analysis

        12.19.2. Market Share Analysis, 2023

            12.19.2.1. By Drug Type

13. Market Structure Analysis

    13.1. Competition Dashboard

    13.2. Competition Benchmarking

    13.3. Market Share Analysis of Top Players

        13.3.1. By Regional

        13.3.2. By Drug Type

14. Competition Analysis

    14.1. Competition Deep Dive

        14.1.1. Quest Diagnostics, Inc.

            14.1.1.1. Overview

            14.1.1.2. Product Portfolio

            14.1.1.3. Profitability by Market Segments

            14.1.1.4. Sales Footprint

            14.1.1.5. Strategy Overview

                14.1.1.5.1. Marketing Strategy

        14.1.2. Abbott Laboratories

            14.1.2.1. Overview

            14.1.2.2. Product Portfolio

            14.1.2.3. Profitability by Market Segments

            14.1.2.4. Sales Footprint

            14.1.2.5. Strategy Overview

                14.1.2.5.1. Marketing Strategy

        14.1.3. Clinical Reference Laboratory, Inc.

            14.1.3.1. Overview

            14.1.3.2. Product Portfolio

            14.1.3.3. Profitability by Market Segments

            14.1.3.4. Sales Footprint

            14.1.3.5. Strategy Overview

                14.1.3.5.1. Marketing Strategy

        14.1.4. Laboratory Corporation of America Holdings

            14.1.4.1. Overview

            14.1.4.2. Product Portfolio

            14.1.4.3. Profitability by Market Segments

            14.1.4.4. Sales Footprint

            14.1.4.5. Strategy Overview

                14.1.4.5.1. Marketing Strategy

        14.1.5. Cordant Health Solutions

            14.1.5.1. Overview

            14.1.5.2. Product Portfolio

            14.1.5.3. Profitability by Market Segments

            14.1.5.4. Sales Footprint

            14.1.5.5. Strategy Overview

                14.1.5.5.1. Marketing Strategy

        14.1.6. Legacy Medical Services, LLC.

            14.1.6.1. Overview

            14.1.6.2. Product Portfolio

            14.1.6.3. Profitability by Market Segments

            14.1.6.4. Sales Footprint

            14.1.6.5. Strategy Overview

                14.1.6.5.1. Marketing Strategy

        14.1.7. DrugScan

            14.1.7.1. Overview

            14.1.7.2. Product Portfolio

            14.1.7.3. Profitability by Market Segments

            14.1.7.4. Sales Footprint

            14.1.7.5. Strategy Overview

                14.1.7.5.1. Marketing Strategy

        14.1.8. Omega Laboratories, Inc.

            14.1.8.1. Overview

            14.1.8.2. Product Portfolio

            14.1.8.3. Profitability by Market Segments

            14.1.8.4. Sales Footprint

            14.1.8.5. Strategy Overview

                14.1.8.5.1. Marketing Strategy

        14.1.9. Psychemedics Corporation

            14.1.9.1. Overview

            14.1.9.2. Product Portfolio

            14.1.9.3. Profitability by Market Segments

            14.1.9.4. Sales Footprint

            14.1.9.5. Strategy Overview

                14.1.9.5.1. Marketing Strategy

        14.1.10. Mayo Clinic Laboratories

            14.1.10.1. Overview

            14.1.10.2. Product Portfolio

            14.1.10.3. Profitability by Market Segments

            14.1.10.4. Sales Footprint

            14.1.10.5. Strategy Overview

                14.1.10.5.1. Marketing Strategy

15. Assumptions & Acronyms Used

16. Research Methodology